Global Pharmaceutical Third-party Logistics (3pl) Market Size & Outlook
Global pharmaceutical third-party logistics (3pl) market, 2018-2030 (US$M)
Related Markets
Global pharmaceutical third-party logistics (3pl) market highlights
- The global pharmaceutical third-party logistics (3pl) market generated a revenue of USD 137,252.0 million in 2024 and is expected to reach USD 228,542.2 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.9% by 2030.
- In terms of segment, branded accounted for a revenue of USD 53,613.1 million in 2024.
- Cell Therapy is the most lucrative product type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 137,252.0 million |
| Market revenue in 2030 | USD 228,542.2 million |
| Growth rate | 8.9% (CAGR from 2025 to 2030) |
| Largest segment | Branded |
| Fastest growing segment | Cell Therapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 38.2% of the global pharmaceutical third-party logistics (3pl) market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 17,343.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Third-Party Logistics (3PL) Market Scope
Pharmaceutical Third-Party Logistics (3PL) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Knipper | View profile | 11-50 | Saarbrücken, Saarland, Germany, Europe | https://knipper.de |
| Kuehne + Nagel | View profile | 10001+ | Schönefeld, Brandenburg, Germany, Europe | https://home.kuehne-nagel.com/ |
| McKesson Corporation | View profile | - | - | - |
| Cardinal Health | View profile | - | - | - |
| EVERSANA | View profile | 5001-10000 | Milwaukee, Wisconsin, United States, North America | https://www.eversana.com |
| CEVA Logistics | View profile | 10001+ | Marseille, Provence-Alpes-Cote d'Azur, France, Europe | https://www.cevalogistics.com/ |
| DB Schenker | View profile | 10001+ | Essen, Nordrhein-Westfalen, Germany, Europe | https://www.dbschenker.com/global |
| Cencora Inc | View profile | 46000 | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 | https://www.cencora.com |
| Kerry Logistics Network Ltd | View profile | 33100 | 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, | https://www.kln.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Global pharmaceutical third-party logistics (3pl) market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical third-party logistics (3pl) market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 39.06% in 2024. Horizon Databook has segmented the Global pharmaceutical third-party logistics (3pl) market based on branded, generic, biosimilar, vaccine, cell therapy, gene therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Pharmaceutical Third-Party Logistics (3PL) Product Type Outlook (Revenue, USD Million, 2018-2030)
- Biosimilar
- Gene Therapy
- Branded
- Generic
- Vaccine
- Cell Therapy
- Others
- Global Pharmaceutical Third-Party Logistics (3PL) Temperature Outlook (Revenue, USD Million, 2018-2030)
- Ambient
- Refrigerated
- Ultra-frozen/Deep-Frozen
- Frozen
- Cryogenic
- Global Pharmaceutical Third-Party Logistics (3PL) Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Cardiovascular Diseases
- Neurology
- Allergy/Asthma
- Gastroenterology
- Ophthalmology
- Infectious Diseases
- Diabetes
- Others
- Oncology
- Nephrology
- Rheumatology
- Global Pharmaceutical Third-Party Logistics (3PL) Manufacturer Size Outlook (Revenue, USD Million, 2018-2030)
- Small
- Large
- Medium
- Global Pharmaceutical Third-Party Logistics (3PL) Services Outlook (Revenue, USD Million, 2018-2030)
- DSCSA and Serialization Services
- Order-to-cash
- Pharmaceutical Sampling
- Storage and Shipping
- Title Model
- Others
Reasons to subscribe to Global pharmaceutical third-party logistics (3pl) market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmaceutical third-party logistics (3pl) market databook
-
Our clientele includes a mix of pharmaceutical third-party logistics (3pl) market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical third-party logistics (3pl) market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical third-party logistics (3pl) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmaceutical third-party logistics (3pl) market size, by regions, 2018-2030 (US$M)
Top 10 countries: Pharmaceutical third-party logistics (3pl) market size, 2024 (US$M)
Global pharmaceutical third-party logistics (3pl) market share, by temperature, 2024 & 2030 (%, US$M)
Pharmaceutical third-party logistics (3pl) market: Opportunity assessment by country
Global pharmaceutical third-party logistics (3pl) market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
